Mengis Capital Management Inc. Has $700,000 Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) (2024)

Mengis Capital Management Inc. trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 61.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,800 shares of the pharmacy operator's stock after selling 42,100 shares during the quarter. Mengis Capital Management Inc.'s holdings in Walgreens Boots Alliance were worth $700,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Walgreens Boots Alliance by 14.5% in the 3rd quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator's stock worth $1,927,656,000 after purchasing an additional 10,962,030 shares during the period. Invesco Ltd. lifted its position in shares of Walgreens Boots Alliance by 21.5% during the 3rd quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator's stock valued at $378,668,000 after acquiring an additional 3,013,807 shares during the period. Morgan Stanley raised its holdings in Walgreens Boots Alliance by 15.8% during the third quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator's stock worth $279,876,000 after buying an additional 1,720,228 shares during the last quarter. International Assets Investment Management LLC raised its holdings in Walgreens Boots Alliance by 1,985.1% during the fourth quarter. International Assets Investment Management LLC now owns 889,546 shares of the pharmacy operator's stock worth $23,226,000 after buying an additional 846,884 shares during the last quarter. Finally, Grantham Mayo Van Otterloo & Co. LLC raised its holdings in Walgreens Boots Alliance by 85.1% during the third quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 1,752,170 shares of the pharmacy operator's stock worth $38,968,000 after buying an additional 805,332 shares during the last quarter. 58.59% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on WBA shares. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a "hold" rating for the company in a research note on Wednesday, April 3rd. Bank of America reduced their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an "underperform" rating for the company in a research note on Tuesday, March 26th. Morgan Stanley reduced their target price on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an "underweight" rating for the company in a research note on Monday, April 1st. Barclays started coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They issued an "underweight" rating and a $21.00 target price for the company. Finally, HSBC reiterated a "reduce" rating and issued a $20.00 target price (down previously from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $24.36.

Check Out Our Latest Report on Walgreens Boots Alliance

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA traded down $0.02 on Monday, reaching $18.22. 7,636,344 shares of the company's stock were exchanged, compared to its average volume of 14,119,906. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The firm has a market cap of $15.72 billion, a price-to-earnings ratio of -2.61, a P/E/G ratio of 1.13 and a beta of 0.73. Walgreens Boots Alliance, Inc. has a 52 week low of $17.51 and a 52 week high of $35.54. The stock has a fifty day simple moving average of $20.42 and a 200-day simple moving average of $21.92.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.82 by $0.38. The firm had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company's revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the prior year, the firm posted $1.16 earnings per share. As a group, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Insider Buying and Selling at Walgreens Boots Alliance

In other news, Director Valerie B. Jarrett bought 4,456 shares of the business's stock in a transaction dated Monday, January 29th. The shares were purchased at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the acquisition, the director now owns 4,456 shares of the company's stock, valued at $99,992.64. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Valerie B. Jarrett purchased 4,456 shares of the stock in a transaction dated Monday, January 29th. The stock was purchased at an average price of $22.44 per share, with a total value of $99,992.64. Following the transaction, the director now directly owns 4,456 shares in the company, valued at $99,992.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Manmohan Mahajan purchased 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The stock was bought at an average cost of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The disclosure for this purchase can be found here. Insiders have acquired 13,456 shares of company stock worth $270,423 over the last ninety days. Insiders own 17.40% of the company's stock.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

See Also

• Five stocks we like better than Walgreens Boots Alliance
• What is the Euro STOXX 50 Index?
• It’s Time to Buy Into the Super Micro Computer Stock Implosion
• Are Penny Stocks a Good Fit for Your Portfolio?
• Merger or Not, Albertson’s Companies is a Good Buy
• About the Markup Calculator
• 3 Cheap Stocks That Shouldn’t Be So

Should you invest $1,000 in Walgreens Boots Alliance right now?

Before you consider Walgreens Boots Alliance, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.

While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here